JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6 | -14.3% | 3,373 | -51.6% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 6,964 | -36.5% | 0.00% | – |
| Q3 2022 | $25,000 | +2400.0% | 10,968 | +3721.6% | 0.00% | – |
| Q1 2022 | $1,000 | -93.3% | 287 | -86.7% | 0.00% | – |
| Q4 2020 | $15,000 | -53.1% | 2,166 | -45.8% | 0.00% | – |
| Q3 2020 | $32,000 | -84.7% | 3,993 | -83.4% | 0.00% | – |
| Q4 2019 | $209,000 | +20800.0% | 24,027 | +10167.9% | 0.00% | – |
| Q2 2019 | $1,000 | – | 234 | +70.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 137 | -99.7% | 0.00% | -100.0% |
| Q3 2018 | $354,000 | +74.4% | 54,541 | +105.6% | 0.00% | 0.0% |
| Q2 2018 | $203,000 | +141.7% | 26,528 | +602.9% | 0.00% | -75.0% |
| Q1 2018 | $84,000 | +147.1% | 3,774 | +37.5% | 0.00% | +300.0% |
| Q4 2017 | $34,000 | – | 2,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |